Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives $513.74 Average PT from Analysts

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have earned an average recommendation of “Moderate Buy” from the nineteen research firms that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and fourteen have issued a buy recommendation on the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $513.74.

ISRG has been the subject of several research reports. Stifel Nicolaus lifted their price target on Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $380.00 to $510.00 in a report on Friday, August 2nd. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Leerink Partners raised their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Finally, Mizuho lifted their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 238 shares of Intuitive Surgical stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $477.50, for a total transaction of $113,645.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,629,115. The trade was a 4.14 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel Gary Loeb sold 300 shares of the company’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the sale, the general counsel now owns 1,595 shares in the company, valued at $757,625. This trade represents a 15.83 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 91,178 shares of company stock valued at $45,897,071. 0.90% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds and other institutional investors have recently made changes to their positions in ISRG. Ridgewood Investments LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter worth approximately $26,000. Godsey & Gibb Inc. lifted its holdings in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the period. Creekmur Asset Management LLC boosted its position in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 42 shares during the last quarter. LGT Financial Advisors LLC boosted its position in Intuitive Surgical by 415.4% during the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 54 shares during the last quarter. Finally, MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical during the 3rd quarter worth about $33,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $527.61 on Wednesday. The firm’s fifty day moving average price is $498.17 and its two-hundred day moving average price is $456.22. The company has a market cap of $187.92 billion, a P/E ratio of 85.96, a P/E/G ratio of 5.28 and a beta of 1.39. Intuitive Surgical has a one year low of $295.02 and a one year high of $544.38.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. As a group, equities research analysts expect that Intuitive Surgical will post 5.45 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.